Exploring Automation to Scale Out Autologous CAR-T Manufacturing
- Examine how automation enables scalable, parallelised production of autologous CAR-T therapies without compromising quality
- Discuss how streamlined, modular manufacturing platforms can lower costs and accelerate patient access